EVENITY solution for injection in pre-filled syringe 105 mg: Each pre-filled syringe contains 105 mg romosozumab in 1.17 mL (90 mg/mL) solution.
EVENITY (romosozumab) is a humanised monoclonal antibody (IgG2) with high affinity and specificity for sclerostin. Romosozumab has an approximate molecular weight of 145 kDa and is produced in a mammalian cell line (Chinese hamster ovary) by recombinant DNA technology.
EVENITY is a sterile, preservative-free, clear to opalescent, colourless to light yellow solution, pH 5.2.
Excipients/Inactive Ingredients: 0.61 mg calcium, 3.8 mg acetate, 70 mg sucrose, 0.07 mg polysorbate 20, Water for Injection, Sodium hydroxide to pH of 5.2.